PISCATAWAY, N.J., Jan. 13, 2009 – GenScript, a biotech company, has just launched its MonoExpress™ monoclonal antibody service. This new service promises to deliver monoclonal antibodies in 60 days, two to four months faster than traditional monoclonal antibody production.
The MonoExpress™ system shortens the time required to generate monoclonal antibodies through the integration of GenScript's proprietary OptimumAntigen™ tool and T-Max™ adjuvant, as well as nanotechnology. GenScript's OptimumAntigen™ tool implements the industry's advanced algorithm screening antigens with enhanced antibody and epitope specificity within several protein databases and T-Max™ adjuvant is able to elicits faster and stronger cellular immune response. These technologies allow the immunization process to be trimmed down to only five weeks. In addition to its speed, GenScript's MonoExpress™ service also promises positive Western blot results and two ELISA positive clones. GenScript representative Dr. Liu reports that this service will appeal to researchers, who are often in urgent need for monoclonal antibodies.
Shortening immunization time is not without difficulty, particularly in projects that involve antigens with poor immunogenicity; however, GenScript still manage to produce quality monoclonal antibodies. In addition, GenScript also offers a 33-day polyclonal express antibody service as a complement to MonoExpress™.
GenScript Corporation is a reliable outsourcing partner providing a wide array of services to augment all stages of the drug discovery and biological reagent manufacturing processes, including high-quality gene synthesis and cloning, custom protein expression and purification, custom peptide synthesis and antibody development, custom stable cell line development, and a wide selection of biological reagents to life science researchers in industrial and academic settings. GenScript Corporation is headquartered in Piscataway, New Jersey.
# # # #
For further information, please contact:
Executive Vice President
Your Innovation Partner in Drug Discovery!